Literature DB >> 18307852

Limited value of chest radiography in predicting aetiology of lower respiratory tract infection in general practice.

A Willy Graffelman1, Francois E J A Willemssen, Harmine M Zonderland, Arie Knuistingh Neven, Aloys C M Kroes, Peterhans J van den Broek.   

Abstract

BACKGROUND: In patients with lower respiratory tract infection (LRTI), changes on chest radiography are rare but poorly characterised, especially in general practice. AIM: To describe the range of findings on chest radiographs and the associations between these findings and the aetiology of LRTI. DESIGN OF STUDY: A prospective observational study.
SETTING: General practices in the Leiden region, The Netherlands.
METHOD: Adult patients with a defined LRTI were included. Standard medical history and physical examination were performed. Sputum, blood, and throat swabs were collected for diagnostic tests. Chest X-ray findings were assessed in relation to the aetiology.
RESULTS: An abnormality on the chest X-ray was observed in 72 (55%) patients. Forty-five patients (35%) had changes due to infection, and 26 (20%) due to pneumonia. Pathogens were detected in 84 patients (33 single bacterial, 43 single viral, and 8 dual). Twelve (29%) patients with a bacterial infection (including dual infections) compared to four (9%) patients with viral infection had pneumonia on the chest X-ray (odds ratio [OR] = 4.0; 95% confidence interval [CI] = 1.2 to 13.8). Using the presence of pneumonia on chest X-ray as a test to predict a bacterial infection, the positive predictive value and the negative predictive value were 75% (CI = 48 to 93%) and 57% (CI = 45 to 69%), respectively.
CONCLUSION: Pneumonia on the chest X-ray was found more frequently in patients with a bacterial infection than in patients with a viral infection. However, the sensitivity and the specificity are such that pneumonia on the chest X-ray is not a reliable test to discriminate between bacterial and non-bacterial LRTI in the general practice setting.

Entities:  

Mesh:

Year:  2008        PMID: 18307852      PMCID: PMC2233958          DOI: 10.3399/bjgp08X264054

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  12 in total

1.  Pulmonary imaging and function in the common cold.

Authors:  T Puhakka; M Lavonius; M Varpula; E Svedström; E Terho; O Ruuskanen
Journal:  Scand J Infect Dis       Date:  2001

2.  Pathogens involved in lower respiratory tract infections in general practice.

Authors:  A Willy Graffelman; Arie Knuistingh Neven; Saskia le Cessie; Aloys C M Kroes; Machiel P Springer; Peterhans J van den Broek
Journal:  Br J Gen Pract       Date:  2004-01       Impact factor: 5.386

3.  Can history and exam alone reliably predict pneumonia?

Authors:  A W Graffelman; S le Cessie; A Knuistingh Neven; F E J A Wilemssen; H M Zonderland; P J van den Broek
Journal:  J Fam Pract       Date:  2007-06       Impact factor: 0.493

4.  Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community.

Authors:  J Macfarlane; W Holmes; P Gard; R Macfarlane; D Rose; V Weston; M Leinonen; P Saikku; S Myint
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

5.  Radiographic resolution of community-acquired pneumonia.

Authors:  R L Mittl; R J Schwab; J S Duchin; J E Goin; S M Albeida; W T Miller
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

Review 6.  Radiology of pneumonia.

Authors:  D S Katz; A N Leung
Journal:  Clin Chest Med       Date:  1999-09       Impact factor: 2.878

7.  Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection.

Authors:  R M Hopstaken; J W Muris; J A Knottnerus; A D Kester; P E Rinkens; G J Dinant
Journal:  Br J Gen Pract       Date:  2003-05       Impact factor: 5.386

8.  Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community.

Authors:  J T Macfarlane; A Colville; A Guion; R M Macfarlane; D H Rose
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

9.  Prospective study of the aetiology and outcome of pneumonia in the community.

Authors:  M A Woodhead; J T Macfarlane; J S McCracken; D H Rose; R G Finch
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

10.  A comparative study of the etiology of adult upper and lower respiratory tract infections in the community.

Authors:  David Lieberman; Devora Lieberman; Igor Korsonsky; Miriam Ben-Yaakov; Zilia Lazarovich; Maureen G Friedman; Bella Dvoskin; Maija Leinonen; Bella Ohana; Ida Boldur
Journal:  Diagn Microbiol Infect Dis       Date:  2002-01       Impact factor: 2.803

View more
  4 in total

Review 1.  Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis.

Authors:  Christian Marchello; Ariella Perry Dale; Thuy Nhu Thai; Duk Soo Han; Mark H Ebell
Journal:  Ann Fam Med       Date:  2016-11       Impact factor: 5.166

2.  Protective Capacity of Statins during Pneumonia Is Dependent on Etiological Agent and Obesity.

Authors:  Erik A Karlsson; Stacey Schultz-Cherry; Jason W Rosch
Journal:  Front Cell Infect Microbiol       Date:  2018-02-15       Impact factor: 5.293

3.  A host gene expression approach for identifying triggers of asthma exacerbations.

Authors:  Emily C Lydon; Charles Bullard; Mert Aydin; Olga M Better; Anna Mazur; Bradly P Nicholson; Emily R Ko; Micah T McClain; Geoffrey S Ginsburg; Chris W Woods; Thomas W Burke; Ricardo Henao; Ephraim L Tsalik
Journal:  PLoS One       Date:  2019-04-08       Impact factor: 3.240

4.  Suspected community-acquired pneumonia in an ambulatory setting (CAPA): a French prospective observational cohort study in general practice.

Authors:  Henri Partouche; Céline Buffel du Vaure; Virginie Personne; Chloé Le Cossec; Camille Garcin; Alain Lorenzo; Christian Ghasarossian; Paul Landais; Laurent Toubiana; Serge Gilberg
Journal:  NPJ Prim Care Respir Med       Date:  2015-03-12       Impact factor: 2.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.